Interested in joining one of our studies? Please browse our open studies below.
QUEST-ADVANCE
The elimination of cervical cancer has been listed by the World Health Organization as a top health priority and Canada is posed to be one of the first countries to achieve this goal. Ongoing evaluation of the HPV vaccine and dosing schedule is critical to optimizing the vaccine’s cancer-eliminating potential.
Women ages 13-27 and men ages 15-20 are invited to participate in this observational study regardless of whether or not they have received the HPV vaccine. Please email questadvance@bcchr.ubc.ca to learn more.
ACE-PROVE
If you are the parent or guardian of a BC student currently in Grade 6, we want to know how you decide on vaccinations for your child.
By taking part in the ACE PROVE survey you will help inform the ongoing monitoring and evaluation of BC’s HPV (human papillomavirus) vaccine program. This study is aligned with the World Health Organization’s goal of completely eliminating cervical cancer and other HPV-related diseases.
The survey is offered in English, Punjabi, Cantonese, or Mandarin and will take 20 minutes to complete. If you have any questions about the survey, or if they are interested in taking part, please write to ACEPROVE@bcchr.ubc.ca.
If you are interested in joining one of our studies or
would like to be added to our contact list, click below.